Lilly’s donanemab reduces Alzheimer’s disease progression in Phase 2 trial
ALZ results revealed by Eli Lilly and Company at the recent 15th International Conference on Alzheimer's & Parkinson Diseases 2021 (AD/PD 2021) expand on...
Brain implants connected to robotic brace to help mobility after stroke?
Brain is still a mystery to even researchers. The latest is: A single patient at Thomas Jefferson University will help researchers learn if brain...
Surprising lack of association between stress and migraine revealed
Surprising it might sound, but a new study has found lack of association between stress and migraine.
The research by the University of Calgary and...
BD Antigen Test more selective in detecting infectious COVID-19 patients: Research
BD (Becton, Dickinson and Company) has announced the publication of a peer-reviewed study that shows BD's antigen test may be more selective than PCR...
SK Biopharmaceuticals, LifeSci Venture Partners announce partnership for Open Innovation
Innovative pharma company SK Biopharmaceuticals, Co., Ltd., has inked a pact with global life science venture capital firm LifeSci Venture Partners to collaborate on...
Is immediate immunity against COVID-19 possible? Grifols starts clinical trial of new treatment
Grifols has announced it will begin a clinical trial in Spain to evaluate the safety and efficacy of a new COVID-19 immunity drug based...
AstraZeneca ties up with CCT to carry out Covid-19 vaccine trials in Arizona
CCT Research has announced forging a partnership with AstraZeneca to advance Covid-19 research.
By joining hands with with local healthcare providers, CCT, a leader in...
Oramed provides doses to patients across multiple sites
Oramed Pharmaceuticals Inc has announced that randomization of patients in its first Phase 3 study of its oral insulin capsule ORMD-0801 for the treatment...
Haoma Medica’s novel treatment for osteoporosis, NaQuinate, undergoes first human trial
Haoma Medica has announced the completion of a first-in-human trial for NaQuinate. A naphthoquinone carboxylic acid, it is being developed as a novel orally...
NIH starts study of Covid infection and multisystem inflammatory syndrome
NIH has started an observational study has launched to evaluate the short- and long-term health outcomes of SARS-CoV-2 infection in children
This includes multisystem inflammatory...
